BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 67 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $166,158 | +286.7% | 159,768 | +375.9% | 0.00% | – |
| Q2 2023 | $42,968 | -89.9% | 33,569 | -89.0% | 0.00% | – |
| Q1 2023 | $425,899 | +839.2% | 306,402 | +778.4% | 0.00% | – |
| Q4 2022 | $45,348 | -56.8% | 34,883 | -50.9% | 0.00% | – |
| Q3 2022 | $105,000 | -87.5% | 71,044 | -82.7% | 0.00% | – |
| Q2 2022 | $838,000 | -27.8% | 410,871 | -3.0% | 0.00% | – |
| Q1 2022 | $1,161,000 | -47.5% | 423,791 | -6.1% | 0.00% | – |
| Q4 2021 | $2,210,000 | -4.2% | 451,108 | +147.5% | 0.00% | – |
| Q3 2021 | $2,306,000 | -46.0% | 182,277 | -34.0% | 0.00% | -100.0% |
| Q2 2021 | $4,272,000 | +2638.5% | 276,334 | +5729.8% | 0.00% | – |
| Q1 2021 | $156,000 | – | 4,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |